Mirtazapine
- Generic Name
- Mirtazapine
- Brand Names
- Remeron
- Drug Type
- Small Molecule
- Chemical Formula
- C17H19N3
- CAS Number
- 85650-52-8
- Unique Ingredient Identifier
- A051Q2099Q
- Background
Mirtazapine is a tetracyclic piperazino-azepine antidepressant agent that was initially approved for the treatment of major depressive disorder (MDD) in the Netherlands in 1994. This drug was first manufactured by Organon Inc., and received FDA approval in 1997 for the treatment of major depressive disorder. The effects of this drug may be observed as early ...
- Indication
This drug is indicated for the treatment of major depressive disorder and its associated symptoms.
...
- Associated Conditions
- Cancer Pain, Depression, Fibromyalgia, Generalized Anxiety Disorder, Hot Flashes, Insomnia, Major Depressive Disorder (MDD), Obsessive Compulsive Disorder (OCD), Panic Disorder, Persistent Depressive Disorder (Dysthymia), Post Operative Nausea and Vomiting (PONV), Poststroke depression, Sleep disorders and disturbances, Substance Abuse Disorders, Tension Headache
- Associated Therapies
- -
Effect of Mirtazapine Versus Placebo in Patients With Non-small Cell Lung Cancer and Anorexia
- Conditions
- Interventions
- First Posted Date
- 2021-02-10
- Last Posted Date
- 2023-04-27
- Lead Sponsor
- Instituto Nacional de Cancerologia de Mexico
- Target Recruit Count
- 86
- Registration Number
- NCT04748523
- Locations
- 🇲🇽
Instituto Nacional de Cancerologia, Mexico City, Mexico
Improving Sleep After TKA Using Mirtazapine and Quetiapine
- Conditions
- Interventions
- First Posted Date
- 2021-01-28
- Last Posted Date
- 2023-06-02
- Lead Sponsor
- St. Anna Ziekenhuis, Geldrop, Netherlands
- Target Recruit Count
- 165
- Registration Number
- NCT04728581
- Locations
- 🇳🇱
St. Anna hospital, Geldrop, Netherlands
🇳🇱Knowledge Center for Orthopedic Surgery, St. Anna hospital, Geldrop, Netherlands
Mirtazapine and Methamphetamine Drug-drug Interaction Study
- Conditions
- Interventions
- First Posted Date
- 2020-11-04
- Last Posted Date
- 2023-11-22
- Lead Sponsor
- San Francisco Department of Public Health
- Target Recruit Count
- 24
- Registration Number
- NCT04614584
- Locations
- 🇺🇸
UCLA Medical Center, Los Angeles, California, United States
🇺🇸San Francisco Department of Public Health, San Francisco, California, United States
🇺🇸Substance Use Research Unit, San Francisco, California, United States
Non-interventional, Retrospective Cohort Study to Explore Antidepressant Treatment in Korea
- First Posted Date
- 2020-06-24
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 370212
- Registration Number
- NCT04446039
- Locations
- 🇰🇷
Pfizer, Seoul, Korea, Republic of
Nutrition and Pharmacological Algorithm for Oncology Patients Study
- First Posted Date
- 2019-11-07
- Last Posted Date
- 2022-11-16
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 1
- Registration Number
- NCT04155008
- Locations
- 🇺🇸
Montefiore Hospital, Bronx, New York, United States
A Study of Esketamine Nasal Spray Plus a New Standard-of-care Oral Antidepressant or Placebo Nasal Spray Plus a New Standard-of-care Oral Antidepressant in Adult and Elderly Participants With Treatment-resistant Depression
- First Posted Date
- 2019-02-25
- Last Posted Date
- 2019-11-26
- Lead Sponsor
- Janssen-Cilag International NV
- Registration Number
- NCT03852160
Validating the Effect og Ondansetron and Mirtazapine in Treating Hyperemesis Gravidarum
- Conditions
- Interventions
- First Posted Date
- 2018-12-24
- Last Posted Date
- 2023-01-30
- Lead Sponsor
- Nordsjaellands Hospital
- Target Recruit Count
- 58
- Registration Number
- NCT03785691
- Locations
- 🇩🇰
Department of Gynaecology and Obstetrics, Aarhus University Hospital, Aarhus, Denmark
🇩🇰Department of Gynaecology and Obstetrics, Rigshospitalet, Copenhagen, Denmark
🇩🇰Department of Gynaecology and Obstetrics, Herlev Hospital, Herlev, Denmark
Prophylactic Mirtazapine or Clonidine for Post-spinal Anesthesia Shivering
- First Posted Date
- 2018-09-20
- Last Posted Date
- 2018-09-20
- Lead Sponsor
- Ain Shams University
- Target Recruit Count
- 300
- Registration Number
- NCT03679052
- Locations
- 🇪🇬
Ibrahim Mamdouh Esmat, Heliopolis, Cairo, Egypt
Prophylactic Mirtazapine or Dexamethasone for Post-spinal Anesthesia Shivering
- Conditions
- Interventions
- First Posted Date
- 2018-09-18
- Last Posted Date
- 2020-12-21
- Lead Sponsor
- Ain Shams University
- Target Recruit Count
- 300
- Registration Number
- NCT03675555
- Locations
- 🇪🇬
Ibrahim Mamdouh Esmat, Heliopolis, Cairo, Egypt
Comparison Between Mirtazapine and Megestrol for the Control of Anorexia-cachexia in Cancer Patients in Palliative Care.
- First Posted Date
- 2017-09-14
- Last Posted Date
- 2023-07-07
- Lead Sponsor
- University of Sao Paulo
- Target Recruit Count
- 52
- Registration Number
- NCT03283488
- Locations
- 🇧🇷
Clinics Hospital, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.